Jazz Interest Debt Per Share from 2010 to 2025

JAZZ Stock  USD 121.18  1.44  1.17%   
Jazz Pharmaceuticals Interest Debt Per Share yearly trend continues to be fairly stable with very little volatility. Interest Debt Per Share is likely to outpace its year average in 2025. During the period from 2010 to 2025, Jazz Pharmaceuticals Interest Debt Per Share regression line of annual values had r-squared of  0.82 and arithmetic mean of  44.38. View All Fundamentals
 
Interest Debt Per Share  
First Reported
2010-12-31
Previous Quarter
86.47
Current Value
90.8
Quarterly Volatility
37.55509557
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Jazz Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jazz Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 349.5 M, Other Operating Expenses of 3.9 B or Operating Income of 698.6 M, as well as many indicators such as Price To Sales Ratio of 2.22, Dividend Yield of 0.0 or PTB Ratio of 2.98. Jazz financial statements analysis is a perfect complement when working with Jazz Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Jazz Pharmaceuticals Correlation against competitors.

Latest Jazz Pharmaceuticals' Interest Debt Per Share Growth Pattern

Below is the plot of the Interest Debt Per Share of Jazz Pharmaceuticals PLC over the last few years. It is Jazz Pharmaceuticals' Interest Debt Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jazz Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Interest Debt Per Share10 Years Trend
Slightly volatile
   Interest Debt Per Share   
       Timeline  

Jazz Interest Debt Per Share Regression Statistics

Arithmetic Mean44.38
Geometric Mean21.74
Coefficient Of Variation84.62
Mean Deviation32.03
Median32.26
Standard Deviation37.56
Sample Variance1,410
Range107
R-Value0.90
Mean Square Error278.87
R-Squared0.82
Slope7.12
Total Sum of Squares21,156

Jazz Interest Debt Per Share History

2025 90.8
2024 86.47
2023 96.08
2022 97.29
2021 107.48
2020 41.9
2019 32.26

About Jazz Pharmaceuticals Financial Statements

Jazz Pharmaceuticals investors use historical fundamental indicators, such as Jazz Pharmaceuticals' Interest Debt Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Jazz Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Interest Debt Per Share 86.47  90.80 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Jazz Stock Analysis

When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.